N-Q 1 stf.htm N-Q~T. ROWE PRICE SCIENCE & TECHNOLOGY FUND, INC. T. Rowe Price Science & Technology Fund, Inc.

ITEM 1. SCHEDULE OF INVESTMENTS




T. ROWE PRICE SCIENCE & TECHNOLOGY FUND    
Unaudited  
March 31, 2006 
Portfolio of Investments
Shares 
Value 
(Cost and value in $000s)    

COMMON STOCKS 96.4%     
HARDWARE 11.9%     
Enterprise Hardware 9.9%     
Dell (1)  6,200,000  184,512 
EMC (1)  10,500,000  143,115 
LG Electronics (KRW)  500,000  40,550 
    368,177 
Supply Chain/Electronic Manufacturing 2.0%     
Flextronics (1)  3,300,000  34,155 
Hon Hai Precision (TWD)  2,000,000  12,385 
Jabil Circuit (1)  600,000  25,716 
    72,256 
Total Hardware    440,433 
HEALTH CARE 1.9%     
Medical Devices 1.8%     
Boston Scientific (1)  2,000,000  46,100 
Medtronic  400,000  20,300 
    66,400 
Pharmaceuticals 0.1%     
Sepracor (1)  100,000  4,881 
    4,881 
Total Health Care    71,281 
IT SERVICES 6.0%     
IT Services 5.6%     
Accenture, Class A  1,150,000  34,580 
IBM  1,500,000  123,705 
Satyam Computer Services Limited (INR)  900,000  17,087 
Tata Consultancy (INR)  800,000  34,516 
    209,888 
Processors 0.4%     
First Data  300,000  14,046 
    14,046 
Total IT Services    223,934 
MEDIA 11.5%     
Gaming 0.7%     
International Game Technology  750,000  26,415 
    26,415 
Internet 10.0%     
Amazon.com (1)  350,000  12,778 
eBay (1)  1,800,000  70,308 
Google, Class A (1)  200,000  78,000 
Monster Worldwide (1)  500,000  24,930 
Yahoo! (1)  5,700,000  183,882 
    369,898 
Media & Entertainment 0.8%     
Time Warner  1,750,000  29,383 
    29,383 
Total Media    425,696 
SEMICONDUCTORS 19.1%     
Analog Semiconductors 7.1%     
Analog Devices  3,100,000  118,699 
Linear Technology  1,300,000  45,604 
Maxim Integrated Products  2,650,000  98,447 
    262,750 
Digital Semiconductors 10.3%     
Altera (1)  1,600,000  33,024 
Broadcom, Class A (1)  100,000  4,316 
Intel  400,000  7,740 
Marvell Technology Group (1)  450,000  24,345 
Microchip Technology  200,000  7,260 
PMC-Sierra (1)  250,000  3,073 
Samsung Electronics (KRW)  195,000  126,434 
Taiwan Semiconductor, Warrants, 2/1/10 (1)  15,000,000  31,216 
Texas Instruments  500,000  16,235 
Xilinx  5,100,000  129,846 
    383,489 
Semiconductor Capital Equipment 1.7%     
Applied Materials  2,250,000  39,398 
KLA-Tencor  250,000  12,090 
Novellus Systems (1)  500,000  12,000 
    63,488 
Total Semiconductors    709,727 
SOFTWARE 26.5%     
Applications Software 6.2%     
Adobe Systems (1)  500,000  17,460 
Cognos (1)  2,200,000  85,580 
NAVTEQ (1)  1,150,000  58,247 
SAP (EUR)  250,000  54,321 
SAP ADR  250,000  13,580 
    229,188 
Consumer Software 2.6%     
Electronic Arts (1)  1,100,000  60,192 
Take-Two Interactive Software (1)  2,000,000  37,320 
    97,512 
Infrastructure Software 11.1%     
Citrix Systems (1)  100,000  3,790 
Microsoft  8,250,000  224,482 
Oracle (1)  10,250,000  140,323 
Red Hat (1)  1,600,000  44,768 
    413,363 
Systems Software 6.6%     
Cogent (1)  1,800,000  33,012 
McAfee (1)  1,000,000  24,330 
Mercury Interactive (1)  22,400  780 
Symantec (1)  6,000,000  100,980 
VeriSign (1)  3,500,000  83,965 
    243,067 
Total Software    983,130 
TELECOM EQUIPMENT 12.9%     
Wireless Equipment 4.2%     
Motorola  500,000  11,455 
Nokia ADR (2)  5,750,000  119,140 
QUALCOMM  500,000  25,305 
    155,900 
Wireline Equipment 8.7%     
Cisco Systems (1)  6,750,000  146,272 
Corning (1)  1,150,000  30,947 
Juniper Networks (1)  7,750,000  148,180 
    325,399 
Total Telecom Equipment    481,299 
TELECOM SERVICES 1.8%     
Wireless - International 0.9%     
Bharti Televentures (INR) (1)  3,500,000  32,810 
    32,810 
Wireline - International 0.9%     
Telus (CAD)  150,000  5,891 
Telus (Non-voting shares)  750,000  29,025 
    34,916 
Total Telecom Services    67,726 
Total Miscellaneous Common Stocks 4.8% (3)    179,772 
Total Common Stocks (Cost $3,812,462)    3,582,998 
SHORT-TERM INVESTMENTS 3.0%     
Money Market Funds 3.0%     
T. Rowe Price Government Reserve Investment Fund     
4.61% (4)(5)  110,429,299  110,429 
Total Short-Term Investments (Cost $110,429)    110,429 
SECURITIES LENDING COLLATERAL 0.2%     
Money Market Trust 0.2%     
State Street Bank and Trust Company of New Hampshire N.A.     
Securities Lending Quality Trust units, 4.663% (5)  6,570,675  6,571 
Total Securities Lending Collateral (Cost $6,571)    6,571 
Total Investments in Securities     
99.6% of Net Assets (Cost $3,929,462)  $ 3,699,998 


  Denominated in U.S. dollars unless otherwise noted 
(1)  Non-income producing 
(2)  All or a portion of this security is on loan at March 31, 2006 
(3)  The identity of certain securities has been concealed to protect the fund while it 
  completes a purchase or selling program for the securities. 
(4)  Affiliated company - see Note 4 
(5)  Seven-day yield 
ADR  American Depository Receipts 
CAD  Canadian Dollar 
EUR  Euro 
HKD  Hong Kong Dollar 
INR  Indian Rupee 
KRW  South Korean Won 
TWD  Taiwan Dollar 


OPTIONS WRITTEN 0.0%    
Electronic Arts, Put, 4/22/06 @ $50.00 (1) 
(1,000) 
(18) 
Total Options Written (Cost $(172))   
(18) 


The accompanying notes are an integral part of this Portfolio of Investments.





T. ROWE PRICE SCIENCE & TECHNOLOGY FUND    
Unaudited  
March 31, 2006 
Notes To Portfolio of Investments



NOTE 1 - SIGNIFICANT ACCOUNTING POLICIES

T. Rowe Price Science & Technology Fund, Inc. (the fund) is registered under the Investment Company Act of 1940 (the 1940 Act) as a diversified, open-end management investment company. The fund seeks to provide long-term capital appreciation.

The accompanying portfolio of investments was prepared in accordance with accounting principles generally accepted in the United States of America, which require the use of estimates made by fund management. Fund management believes that estimates and security valuations are appropriate; however actual results may differ from those estimates, and the security valuations reflected in the portfolio of investments may differ from the value the fund receives upon sale of the securities.

Valuation

The fund values its investments and computes its net asset value per share at the close of the New York Stock Exchange (NYSE), normally 4 p.m. ET, each day that the NYSE is open for business. Equity securities listed or regularly traded on a securities exchange or in the over-the-counter market are valued at the last quoted sale price or, for certain markets, the official closing price at the time the valuations are made, except for OTC Bulletin Board securities, which are valued at the mean of the latest bid and asked prices. A security that is listed or traded on more than one exchange is valued at the quotation on the exchange determined to be the primary market for such security. Listed securities not traded on a particular day are valued at the mean of the latest bid and asked prices for domestic securities and the last quoted sale price for international securities.

Investments in mutual funds are valued at the mutual fund’s closing net asset value per share on the day of valuation. Purchased and written options are valued at the mean of the closing bid and asked prices.

Other investments and those for which the above valuation procedures are inappropriate or are deemed not to reflect fair value are stated at fair value as determined in good faith by the T. Rowe Price Valuation Committee, established by the fund’s Board of Directors.

Most foreign markets close before the close of trading on the NYSE. If the fund determines that developments between the close of a foreign market and the close of the NYSE will, in its judgment, materially affect the value of some or all of its portfolio securities, which in turn will affect the fund’s share price, the fund will adjust the previous closing prices to reflect the fair value of the securities as of the close of the NYSE, as determined in good faith by the T. Rowe Price Valuation Committee, established by the fund’s Board of Directors. A fund may also fair value securities in other situations, such as when a particular foreign market is closed but the fund is open. In deciding whether to make fair value adjustments, the fund reviews a variety of factors, including developments in foreign markets, the performance of U.S. securities markets, and the performance of instruments trading in U. S. markets that represent foreign securities and baskets of foreign securities. The fund uses outside pricing services to provide it with closing market prices and information used for adjusting those prices. The fund cannot predict when and how often it will use closing prices and when it will adjust those prices to reflect fair value. As a means of evaluating its fair value process, the fund routinely compares closing market prices, the next day’s opening prices in the same markets, and adjusted prices.

Investment Transactions

Investment transactions are accounted for on the trade date.



NOTE 2 - INVESTMENT TRANSACTIONS

Consistent with its investment objective, the fund engages in the following practices to manage exposure to certain risks or enhance performance. The investment objective, policies, program, and risk factors of the fund are described more fully in the fund’s prospectus and Statement of Additional Information.

Options

The fund may invest in call and put options that give the holder the right to purchase or sell, respectively, a security at a specified price on a certain date. Risks arise from possible illiquidity of the options market and from movements in security values. Options are reflected in the accompanying Portfolio of Investments at market value.

Securities Lending

The fund lends its securities to approved brokers to earn additional income. It receives as collateral cash and U.S. government securities valued at 102% to 105% of the value of the securities on loan. Cash collateral is invested in a money market pooled trust managed by the fund’s lending agent in accordance with investment guidelines approved by fund management. Collateral is maintained over the life of the loan in an amount not less than the value of loaned securities, as determined at the close of fund business each day; any additional collateral required due to changes in security values is delivered to the fund the next business day. Although risk is mitigated by the collateral, the fund could experience a delay in recovering its securities and a possible loss of income or value if the borrower fails to return the securities. At March 31, 2006, the value of loaned securities was $6,260,000; aggregate collateral consisted of $6,571,000 in the money market pooled trust.



NOTE 3 - FEDERAL INCOME TAXES

At March 31, 2006, the cost of investments for federal income tax purposes was $3,929,462,000. Net unrealized loss aggregated $228,945,000 at period-end, of which $251,580,000 related to appreciated investments and $480,525,000 related to depreciated investments.



NOTE 4 - RELATED PARTY TRANSACTIONS

The fund may invest in the T. Rowe Price Reserve Investment Fund and the T. Rowe Price Government Reserve Investment Fund (collectively, the T. Rowe Price Reserve Funds), open-end management investment companies managed by Price Associates and affiliates of the fund. The T. Rowe Price Reserve Funds are offered as cash management options to mutual funds, trusts, and other accounts managed by Price Associates and/or its affiliates, and are not available for direct purchase by members of the public. The T. Rowe Price Reserve Funds pay no investment management fees. During the three months ended March 31, 2006, dividend income from the T. Rowe Price Reserve Funds totaled $1,316,000, and the value of shares of the T. Rowe Price Reserve Funds held at March 31, 2006 and December 31, 2005 was $110,429,000 and $44,656,000, respectively.




Item 2. Controls and Procedures.

(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-Q was recorded, processed, summarized, and reported timely.

(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3. Exhibits.

Separate certifications by the registrant's principal executive officer and principal financial officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and required by Rule 30a-2(a) under the Investment Company Act of 1940, are attached.




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

T. Rowe Price Science & Technology Fund, Inc.

By  /s/ Edward C. Bernard 
  Edward C. Bernard 
  Principal Executive Officer 
 
Date  May 19, 2006 


Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By  /s/ Edward C. Bernard 
  Edward C. Bernard 
  Principal Executive Officer 
 
Date  May 19, 2006 
 
 
By  /s/ Joseph A. Carrier 
  Joseph A. Carrier 
  Principal Financial Officer 
 
Date  May 19, 2006